Sleep Disorders  >>  piromelatine (Neu P11)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
piromelatine (Neu P11) / Neurim
NCT01489969: Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients

Completed
2
137
US
Neu-P11, Melatonin agonist
Neurim Pharmaceuticals Ltd.
Primary Insomnia
05/12
01/13

Download Options